×

What are you searching for?




Healthcare

4 Min read

THE POTENTIAL COVID – 19 VACCINE OF BIONTECH AND PFIZER ENTERS A LATE-STAGE HUMAN TRIAL

Published On 28 Jul 2020 06:34 AM


SHARE THIS ARTICLE  


Highlights

  • Up to 30,000 participants will be included in the trial
  • They expect to submit it for final regulatory review by October, if successful

Pfizer and BioNTech began their late-stage human trial for a potential corona virus vaccine. The respective U.S. drug maker and German biotech companies said the same on Monday. The pharmaceutical companies race to win regulatory approva....


Tags : COVID - 19 Pandemic, Corona virus cases, Corona virus vaccine, Pfizer, BioNTech,
SHARE THIS ARTICLE  

Leave a comment 

comments (0)